Tempest Therapeutics (TPST) Q2 2023 Earnings

10AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.8
-0.71
-0.61
-0.52

Details

Expected EPS
-0.52
Actual EPS
-0.54
Surprise EPS
-0.02
Surprise Percent
+3.85%

Description

Tempest Therapeutics (TPST) has reported earnings of -0.54 per share for Q2 2023.

0 Comments

Share your thoughts